Traumatic Brain Injuries (TBI) are often invisible on conventional MRI or CT scans. For patients, that means ongoing symptoms without clear answers. For attorneys and physicians, it means cases and treatment decisions built on uncertainty.
That changes with Diffusion Tensor Imaging (DTI).
Through an exclusive partnership, Smart Scan Medical Imaging and Brain Mapping Solutions bring advanced DTI technology to Wisconsin. This breakthrough provides objective, measurable proof of neurological damage—evidence that supports accurate medical diagnoses and stronger legal cases.
Our advanced imaging impacts multiple fields — from legal to medical to research. Select your area of interest to learn more.
For Healthcare Providers — Neurosurgeons, Orthopedic Surgeons, Neurologists, Rehab Physicians:
Through our exclusive partnership, Smart Scan Medical Imaging + Brain Mapping Solutions deliver clarity where standard imaging falls short. Our AI-enhanced technology uncovers microscopic brain changes that are invisible to MRI and CT scans. This provides the quantitative evidence needed to demonstrate objective neurological damage and validate a patient's symptoms with medical evidence.
Scans are interpreted by fellowship-trained, board-certified radiologists who specialize in advanced neuroimaging and brain injury detection. They also understand both clinical care and legal implications. Patients benefit from fast scheduling, rapid results, and in-network coverage, making advanced imaging accessible and cost-effective.
Smart Scan Medical Imaging is the exc lusive provider of Brain Mapping Solutions' advanced DTI technology in Wisconsin. This partnership is supported by a nationwide network of over 125 centers, offering unmatched expertise and reach.
With SmartScan + BMS, invisible injuries become visible—turning uncertainty into objective proof for better medical care and stronger legal cases.
It’s a cutting-edge neuroimaging approach that uses patented software, modern MRI/DTI protocols, and specialized radiology expertise to detect brain injuries and neurodegenerative conditions that standard scans often miss.
Neuropsyche screening is designed to identify the cognitive and behavioral impairments commonly associated with mild to severe traumatic brain injury. Based on the results, a tailored treatment program can be created. In some cases, this process can be supported via telemedi cine through licensed forensic neuropsychologists.
With access to over 100 imaging centers nationwide—including academic institutions, hospitals, and trauma centers—patients can undergo specialized MRI/DTI scans at a location near them. Images are securely uploaded to a HIPAA - compliant platform where expert neuroradiologists review and report the findings.
Neuro-Infuse is a proprietary multimodal therapy developed to address multiple factors that contribute to long-term cognitive decline after TBI, including oxidative stress, edema, excitotoxicity, and cell death. The therapy incorporates vitamins, glutathione, amino acids, and cofactors. It is non-toxic, safe, and supported by an increasing body of research on TBI recovery.
This technology and treatment approach has been applied to professional athletes, individuals living with degenerative conditions, and TBI patients seeking answers about their brain health. It is also being used to demonstrate positive changes following advanced therapeutic interventions.
Using proprietary DTI imaging software combined with MRI (1.5T or 3T magnets), subtle brain changes can be identified that are invisible to traditional imaging. These findings are processed through an FDA-,cleared viewer, providing clear, measurable evidence of injury.
Nutraceuticals have gained attention for their neuroprotective properties. Laboratory research has shown that certain compounds offer multi-mechanistic support for brain health, which makes them a promising tool for the treatment and management of TBI.
Yes. Once scans are completed and analyzed, a consultation can be arranged with a neuroradiologist to review findings and discuss next steps.
Through FDA-cleared MRI/DTI post-processing, clinicians can pinpoint the exact regions of the brain affected by injury and connect those findings to potential cognitive or behavioral deficits. This provides clarity for patients, families, and care teams, helping guide treatment and decision-making.
